We could not find any results for:
Make sure your spelling is correct or try broadening your search.
E-Z-EM, Inc. (NASDAQ: EZEM) announced today it had completed the merger of Eagle Acquisition Sub, Inc., a wholly owned subsidiary of Bracco Diagnostics, Inc. (Bracco), the...
E-Z-EM, Inc. (NASDAQ: EZEM) announced today that the stockholders of the Company voted to adopt the merger agreement providing for the acquisition of the Company by Bracco...
E-Z-EM, Inc. (NASDAQ:EZEM) today announced financial results for the quarter and first half of 2008 ending December 1, 2007. Highlights of the fiscal year 2008 second quarter...
E-Z-EM, Inc. (NASDAQ:EZEM) today announced financial results for its fiscal 2007 fourth quarter and fiscal year. Highlights for the quarter ended June 2, 2007 and recent weeks...
E-Z-EM, Inc. (NASDAQ:EZEM) today announced that the U.S. Army Space & Missile Defense Command (USASMD) has placed an additional order for the Company?s RSDLTM personal skin...
E-Z-EM, Inc. (NASDAQ:EZEM) today announced preliminary financial results for its 2007 fiscal year-end. The Company expects net sales of approximately $137.8 million and net...
E-Z-EM, Inc., (NASDAQ:EZEM) today announced that Tyco Healthcare Group LP filed a lawsuit against the Company in the federal district court in Texas alleging patent infringement...
Stock exchange and ticker symbol in release dated May 8, 2007 should read: (NASDAQ:EZEM). The corrected release reads: ADEL MICHAEL JOINS E-Z-EM BOARD OF DIRECTORS...
E-Z-EM, Inc. (NASDAQ:EZEM) today announced that Dennis J. Curtin, Senior Vice President-Chief Financial Officer (CFO), has resigned to pursue other opportunities. Joseph...
E-Z-EM, Inc. (NASDAQ:EZEM) today announced that the Company has received 510(k) clearance from the Food and Drug Administration (FDA) for its EmpowerMRTM injector system?the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions